143 related articles for article (PubMed ID: 33431054)
1. Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients.
Lin PC; Chen HO; Lee CJ; Yeh YM; Shen MR; Chiang JH
Hum Genomics; 2021 Jan; 15(1):3. PubMed ID: 33431054
[TBL] [Abstract][Full Text] [Related]
2. Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer.
Bobyn A; Zarrei M; Zhu Y; Hoffman M; Brenner D; Resnick AC; Scherer SW; Gallo M
BMC Med Genet; 2020 May; 21(1):92. PubMed ID: 32375678
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
4. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
5. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
[TBL] [Abstract][Full Text] [Related]
6. Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.
Lin PC; Yeh YM; Wu PY; Hsu KF; Chang JY; Shen MR
Sci Rep; 2019 Mar; 9(1):3931. PubMed ID: 30850667
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
8. Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
Choi YJ; Ohn JH; Kim N; Kim W; Park K; Won S; Sael L; Shin CM; Lee SM; Lee S; An HJ; Jang DM; Han BW; Lee HS; Kang SJ; Kim JS; Lee DH
PLoS One; 2020; 15(7):e0236197. PubMed ID: 32701958
[TBL] [Abstract][Full Text] [Related]
9. The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer.
Chan RH; Chen PC; Yeh YM; Lin BW; Yang KD; Shen MR; Lin PC
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204406
[TBL] [Abstract][Full Text] [Related]
10. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
[TBL] [Abstract][Full Text] [Related]
11. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China].
Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H
Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767
[No Abstract] [Full Text] [Related]
13. Clinical detection of deletion structural variants in whole-genome sequences.
Noll AC; Miller NA; Smith LD; Yoo B; Fiedler S; Cooley LD; Willig LK; Petrikin JE; Cakici J; Lesko J; Newton A; Detherage K; Thiffault I; Saunders CJ; Farrow EG; Kingsmore SF
NPJ Genom Med; 2016; 1():16026. PubMed ID: 29263817
[TBL] [Abstract][Full Text] [Related]
14. Germline genetic regulation of the colorectal tumor immune microenvironment.
Schmit SL; Tsai YY; Bonner JD; Sanz-Pamplona R; Joshi AD; Ugai T; Lindsey SS; Melas M; McDonnell KJ; Idos GE; Walker CP; Qu C; Kast WM; Da Silva DM; Glickman JN; Chan AT; Giannakis M; Nowak JA; Rennert HS; Robins HS; Ogino S; Greenson JK; Moreno V; Rennert G; Gruber SB
BMC Genomics; 2024 Apr; 25(1):409. PubMed ID: 38664626
[TBL] [Abstract][Full Text] [Related]
15. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
17. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
18. Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy.
Lin PC; Yeh YM; Chan RH; Lin BW; Chen PC; Pan CC; Shen MR
BMC Cancer; 2021 Mar; 21(1):217. PubMed ID: 33653301
[TBL] [Abstract][Full Text] [Related]
19. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
20. Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse.
Werdyani S; Yu Y; Skardasi G; Xu J; Shestopaloff K; Xu W; Dicks E; Green J; Parfrey P; Yilmaz YE; Savas S
Cancer Med; 2017 Jun; 6(6):1220-1232. PubMed ID: 28544645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
